PRESS RELEASE published on 10/31/2025 at 14:08, 10 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.62% stake in Qualcomm Incorporated as of 30-Oct-2025 through Form 8.3 filing Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure Qualcomm Incorporated
PRESS RELEASE published on 10/31/2025 at 14:06, 10 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.67% stake in Avadel Pharmaceuticals plc as of 30 October 2025 Vanguard Group Financial Disclosure Stake Disclosure Investments Avadel Pharmaceuticals
BRIEF published on 10/30/2025 at 14:51, 10 months 17 days ago The Vanguard Group Reports Stake in NCC Group plc Form 8.3 The Vanguard Group Shareholding Cyber Security NCC Group
BRIEF published on 10/30/2025 at 14:50, 10 months 17 days ago The Vanguard Group Discloses Interests in Mural Oncology Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Mural Oncology
BRIEF published on 10/30/2025 at 14:48, 10 months 17 days ago Vanguard's Stake in JTC plc Disclosed in Recent Filing Form 8.3 Takeover Code Vanguard Group Equity Position JTC Plc
BRIEF published on 10/30/2025 at 14:47, 10 months 17 days ago The Vanguard Group Reports Position in Just Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group Plc
PRESS RELEASE published on 10/30/2025 at 14:46, 10 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.90% interest in NCC Group plc as of 29-Oct-2025. Details in Form 8.3 public disclosure The Vanguard Group, Inc. Form 8.3 Stock Market Interest Disclosure NCC Group Plc
BRIEF published on 10/30/2025 at 14:45, 10 months 17 days ago Vanguard Discloses Interest in Spire Healthcare Form 8.3 Takeover Code Vanguard Group Spire Healthcare Stock Disclosure
PRESS RELEASE published on 10/30/2025 at 14:45, 10 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc. Form 8.3 filed with the Irish Takeover Panel on 30-Oct-2025 Form 8.3 Irish Takeover Panel Vanguard Group Interest Disclosure Mural Oncology Plc
BRIEF published on 10/30/2025 at 14:44, 10 months 17 days ago The Vanguard Group Discloses Stake in Big Yellow Group plc Ordinary Shares The Vanguard Group Takeover Code Stake Disclosure Big Yellow Group
Published on 09/16/2026 at 16:55, 3 hours 39 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 5 hours 34 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 6 hours 34 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 7 hours 4 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 13:23, 7 hours 11 minutes ago SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 20:27, 7 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 1 hour 29 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 18:22, 2 hours 12 minutes ago EQS-Adhoc: elumeo SE resolves on a capital increase against cash contributions, ex-cluding pre-emptive rights, and a move to the Scale segment
Published on 09/16/2026 at 18:11, 2 hours 23 minutes ago EQS-Adhoc: Berentzen-Gruppe Aktiengesellschaft confirms rumours regarding negotiations on a voluntary takeover offer by SAZERAC COMPANY, INC.
Published on 09/16/2026 at 18:05, 2 hours 29 minutes ago LawZero receives a commitment of up to $300M in joint funding from Canada and Germany
Published on 09/16/2026 at 17:45, 2 hours 49 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 13 hours 34 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 2 hours ago Report on the Combined General Meeting of the 10th of September 2026
